Sanjivani Paranteral (531569) Stock Overview
Operates as a pharmaceutical company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
531569 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sanjivani Paranteral Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹208.00 |
| 52 Week High | ₹396.95 |
| 52 Week Low | ₹193.00 |
| Beta | -0.94 |
| 1 Month Change | -5.02% |
| 3 Month Change | -6.01% |
| 1 Year Change | -33.75% |
| 3 Year Change | 323.63% |
| 5 Year Change | 2,134.16% |
| Change since IPO | 510.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531569 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.3% | -0.9% | -1.4% |
| 1Y | -33.7% | -5.6% | -0.3% |
Return vs Industry: 531569 underperformed the Indian Pharmaceuticals industry which returned -5.6% over the past year.
Return vs Market: 531569 underperformed the Indian Market which returned -0.3% over the past year.
Price Volatility
| 531569 volatility | |
|---|---|
| 531569 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.1% |
Stable Share Price: 531569's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 531569's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 40 | Ashwani Khemka | www.sanjivani.co.in |
Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops.
Sanjivani Paranteral Limited Fundamentals Summary
| 531569 fundamental statistics | |
|---|---|
| Market cap | ₹2.57b |
| Earnings (TTM) | ₹81.11m |
| Revenue (TTM) | ₹715.54m |
Is 531569 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531569 income statement (TTM) | |
|---|---|
| Revenue | ₹715.54m |
| Cost of Revenue | ₹413.38m |
| Gross Profit | ₹302.16m |
| Other Expenses | ₹221.05m |
| Earnings | ₹81.11m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.60 |
| Gross Margin | 42.23% |
| Net Profit Margin | 11.34% |
| Debt/Equity Ratio | 20.4% |
How did 531569 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 12:08 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sanjivani Paranteral Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.